Serum growth differentiation factor 15 is a novel biomarker with high predictive capability for liver cancer occurrence in patients with MASLD regardless of liver fibrosis.

Shusuke KumazakiHayato HikitaYuki TahataJi Hyun SungKenji FukumotoYuta MyojinSadatsugu SakaneKazuhiro MuraiYoichi SasakiKumiko ShiraiYoshinobu SaitoTakahiro KodamaNaruyasu KakitaHirokazu TakahashiHidenori Toyoda Goki SudaEiichi MoriiTakashi KojimaTakeshi EbiharaKentaro ShimizuYutaka SasakiTomohide TatsumiTetsuo Takehara

Published in: Alimentary pharmacology & therapeutics (2024)

Serum GDF15 is a biomarker for liver cancer with high predictive capability and is useful for identifying MASLD patients requiring regular surveillance.

Keyphrases

liver fibrosis
end stage renal disease
ejection fraction
newly diagnosed
chronic kidney disease
public health
risk assessment
prognostic factors